KRISTINA GARDNER: Open Payments
NPI 1790167724 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,363 in 69 payments from 19 companies in 2025. Trend: 2023 $904 · 2024 $1,556 · 2025 $1,363
Food & beverage: $1,363
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $207 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $190 |
| ABBVIE INC. | 10 | $170 |
| Novo Nordisk Inc | 6 | $112 |
| AstraZeneca Pharmaceuticals LP | 4 | $94 |
| Vanda Pharmaceuticals Inc. | 4 | $89 |
| Exact Sciences Corporation | 5 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Amgen Inc. | 4 | $60 |
| Axsome Therapeutics, Inc. | 3 | $58 |
Products named: XIFAXAN, JARDIANCE, MOUNJARO, VRAYLAR, Cologuard Collection Kit, FARXIGA, HETLIOZ, Wegovy.
Industry payments across NC — which companies pay providers there.
